These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 1056006)
61. Limited proteolysis of a chemically modified third component of human complement, C3, by cathepsin G of human leukocytes. Matsuda T; Nagasawa S; Koide T; Koyama J J Biochem; 1985 Jul; 98(1):229-36. PubMed ID: 4044552 [TBL] [Abstract][Full Text] [Related]
62. Isolation and characterization of a 33,000-dalton fragment of complement Factor B with catalytic and C3b binding activity. Lambris JD; Müller-Eberhard HJ J Biol Chem; 1984 Oct; 259(20):12685-90. PubMed ID: 6567645 [TBL] [Abstract][Full Text] [Related]
63. Flavoxobin, a serine protease from Trimeresurus flavoviridis (habu snake) venom, independently cleaves Arg726-Ser727 of human C3 and acts as a novel, heterologous C3 convertase. Yamamoto C; Tsuru D; Oda-Ueda N; Ohno M; Hattori S; Kim ST Immunology; 2002 Sep; 107(1):111-7. PubMed ID: 12225369 [TBL] [Abstract][Full Text] [Related]
64. Human anaphylatoxin (C3a) from the third component of complement. Primary structure. Hugli TE J Biol Chem; 1975 Nov; 250(21):8293-301. PubMed ID: 1238393 [TBL] [Abstract][Full Text] [Related]
65. The apolipoprotein(a) moiety of lipoprotein(a) interacts with the complement activation fragment iC3b but does not functionally affect C3 activation or degradation. Seifert PS; Roth I; Zioncheck TF Atherosclerosis; 1992 Apr; 93(3):209-16. PubMed ID: 1534227 [TBL] [Abstract][Full Text] [Related]
67. Purification and characterization of bovine complement component C3 and its cleavage products. Di Carlo AL; Paape MJ; Hellman J; Lilius EM Am J Vet Res; 1997 Jun; 58(6):585-9. PubMed ID: 9185962 [TBL] [Abstract][Full Text] [Related]
68. Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance. Theofilopoulos AN; Bokisch VA; Dixon FJ J Exp Med; 1974 Mar; 139(3):696-711. PubMed ID: 4591176 [TBL] [Abstract][Full Text] [Related]
69. Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. Alper CA; Abramson N; Johnston RB; Jandl JH; Rosen FS J Clin Invest; 1970 Nov; 49(11):1975-85. PubMed ID: 4097977 [TBL] [Abstract][Full Text] [Related]
70. Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies. Hack CE; Paardekooper J; Smeenk RJ; Abbink J; Eerenberg AJ; Nuijens JH J Immunol; 1988 Sep; 141(5):1602-9. PubMed ID: 2457622 [TBL] [Abstract][Full Text] [Related]
71. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114 [TBL] [Abstract][Full Text] [Related]
72. Component C3 of hagfish complement has a unique structure: identification of native C3 and its degradation products. Fujii T; Nakamura T; Tomonaga S Mol Immunol; 1995 Jun; 32(9):633-42. PubMed ID: 7643855 [TBL] [Abstract][Full Text] [Related]
73. Binding of fluid-phase complement components C3 and C3b to human lymphocytes. Sim E; Sim RB Biochem J; 1981 Sep; 198(3):509-18. PubMed ID: 7326019 [TBL] [Abstract][Full Text] [Related]
74. C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast. Leivo I; Engvall E J Cell Biol; 1986 Sep; 103(3):1091-100. PubMed ID: 3488995 [TBL] [Abstract][Full Text] [Related]
75. The covalent-binding reaction of complement component C3. Sim RB; Twose TM; Paterson DS; Sim E Biochem J; 1981 Jan; 193(1):115-27. PubMed ID: 7305916 [TBL] [Abstract][Full Text] [Related]
76. A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbits. Hoeprich PD; Dahinden CA; Lachmann PJ; Davis AE; Hugli TE J Biol Chem; 1985 Mar; 260(5):2597-600. PubMed ID: 3871772 [TBL] [Abstract][Full Text] [Related]
77. Polypeptide fragments of the third component of complement in urine of hereditary nephritis patients. Chiu FJ; Atkin CL J Immunol; 1985 Jun; 134(6):4057-61. PubMed ID: 3989305 [TBL] [Abstract][Full Text] [Related]
78. Lymphokine production by C3b-stimulated B cells. Sandberg AL; Wahl SM; Mergenhagen SE J Immunol; 1975 Jul; 115(1):139-44. PubMed ID: 1080163 [TBL] [Abstract][Full Text] [Related]
79. Characterization of the lymphocyte membrane receptor for factor H (beta 1H-globulin) with an antibody to anti-factor H idiotype. Lambris JD; Ross GD J Exp Med; 1982 May; 155(5):1400-11. PubMed ID: 6461713 [TBL] [Abstract][Full Text] [Related]
80. Functional and structural characterization of four mouse monoclonal antibodies to complement C3 with potential therapeutic and diagnostic applications. Subías Hidalgo M; Yébenes H; Rodríguez-Gallego C; Martín-Ambrosio A; Domínguez M; Tortajada A; Rodríguez de Córdoba S; Llorca O Eur J Immunol; 2017 Mar; 47(3):504-515. PubMed ID: 28083930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]